Bjornar Gilje
Stavanger, 4068, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway.
Journal: Clinical and experimental medicine
Published: December 05, 2025
Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics.
Journal: Molecular oncology
Published: July 11, 2025
Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: June 17, 2025
Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study.
Journal: Breast (Edinburgh, Scotland)
Published: May 27, 2025
Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives.
Journal: Clinical breast cancer
Published: March 17, 2025
Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials.
Journal: Molecular oncology
Published: February 14, 2024
Raising the quality of cancer treatment
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: January 23, 2024
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1).
Journal: ESMO open
Published: January 18, 2024
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial.
Journal: Journal for immunotherapy of cancer
Published: December 27, 2023
IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results.
Journal: Acta oncologica (Stockholm, Sweden)
Published: December 21, 2023
Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer.
Journal: JCO precision oncology
Published: December 01, 2023
Last Updated: 09/26/2026